Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 62.18% | -2.96% | 313.74% | 4.34% | 8.55% |
| Total Depreciation and Amortization | -37.50% | -21.21% | 0.00% | -3.03% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 174.63% | 25.53% | 63.21% | 306.51% | 196.92% |
| Change in Net Operating Assets | -85.82% | 9.96% | -192.90% | -20.87% | -17.02% |
| Cash from Operations | 7.58% | 5.73% | 3,598.03% | 0.73% | 2.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -641.84% | -181.43% | 417.31% | -746.15% | 231.85% |
| Cash from Investing | -641.84% | -181.72% | 416.95% | -746.32% | 232.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30,357.98% | -92.25% | -97.32% | -- | -97.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30,357.98% | -92.25% | -97.32% | -- | -97.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.63% | -83.04% | 263.08% | -115.92% | 29.19% |